Cargando…

Immune landscape and biomarkers for immuno-oncology in colorectal cancers

Recent advances in immuno-oncology have increased understanding of the tumor immune microenvironment (TIME), and clinical trials for immune checkpoint inhibitor treatment have shown remission and/or durable response in certain proportions of patients stratified by predictive biomarkers. The TIME in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bae, Jeong Mo, Yoo, Seung-Yeon, Kim, Jung Ho, Kang, Gyeong Hoon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society of Pathologists and the Korean Society for Cytopathology 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7483026/ https://www.ncbi.nlm.nih.gov/pubmed/32580539 http://dx.doi.org/10.4132/jptm.2020.05.15

Ejemplares similares

Genomic and transcriptomic characterization of heterogeneous immune subgroups of microsatellite instability-high colorectal cancers
por: Kim, Jung Ho, et al.
Publicado: (2021)

The evolving landscape of predictive biomarkers in immuno‐oncology with a focus on spatial technologies
por: Sadeghi Rad, Habib, et al.
Publicado: (2020)

Pathologic Factors Associated with Prognosis after Adjuvant Chemotherapy in Stage II/III Microsatellite-Unstable Colorectal Cancers
por: Kim, Jung Ho, et al.
Publicado: (2015)

Clinicopathological Characterization and Prognostic Implication of SMAD4 Expression in Colorectal Carcinoma
por: Yoo, Seung-Yeon, et al.
Publicado: (2019)

Advancing translational research for colorectal immuno-oncology
por: Thomas, Elaine M., et al.
Publicado: (2023)

Rapidly Evolving Landscape and Future Horizons in Hepatocellular Carcinoma in the Era of Immuno-Oncology
por: Kang, Sandra Mirie, et al.
Publicado: (2022)

Inflammation, Biomarkers and Immuno-Oncology Pathways in Pancreatic Cancer
por: Lee, Belinda, et al.
Publicado: (2019)

Immuno-Oncology Biomarkers for Personalized Immunotherapy in Breast Cancer
por: Vafaizadeh, Vida, et al.
Publicado: (2020)

Clinicopathologic, molecular, and prognostic implications of the loss of EPCAM expression in colorectal carcinoma
por: Kim, Jung Ho, et al.
Publicado: (2015)

A comparative prognostic performance of definitions of Crohn-like lymphoid reaction in colorectal carcinoma
por: Kim, Younghoon, et al.
Publicado: (2021)

Immuno-Oncology
por: Chaudhuri, Swapna
Publicado: (2017)

Distinct features between MLH1-methylated and unmethylated colorectal carcinomas with the CpG island methylator phenotype: implications in the serrated neoplasia pathway
por: Kim, Jung Ho, et al.
Publicado: (2016)

Role of AI and digital pathology for colorectal immuno-oncology
por: Bilal, Mohsin, et al.
Publicado: (2022)

Insights into immuno-oncology drug development landscape with focus on bone metastasis
por: Kähkönen, Tiina E., et al.
Publicado: (2023)

Overexpression of POSTN in Tumor Stroma Is a Poor Prognostic Indicator of Colorectal Cancer
por: Oh, Hyeon Jeong, et al.
Publicado: (2017)

Biomarkers of Targeted Therapy and Immuno-Oncology in Cancers Metastatic to the Breast
por: Vranic, Semir, et al.
Publicado: (2020)

Landscape of KRAS(G12C), Associated Genomic Alterations, and Interrelation With Immuno-Oncology Biomarkers in KRAS-Mutated Cancers
por: Salem, Mohamed E., et al.
Publicado: (2022)

Bringing the Next Generation of Immuno-Oncology Biomarkers to the Clinic
por: Cesano, Alessandra, et al.
Publicado: (2018)

Prognostic Impact of Fusobacterium nucleatum Depends on Combined Tumor Location and Microsatellite Instability Status in Stage II/III Colorectal Cancers Treated with Adjuvant Chemotherapy
por: Oh, Hyeon Jeong, et al.
Publicado: (2019)

Evolving landscape and academic attitudes toward the controversies of global immuno‐oncology trials
por: Xu, Cheng, et al.
Publicado: (2021)

Immuno‐Oncology in China
por: Lu, Shun, et al.
Publicado: (2019)

Radiomics in immuno-oncology
por: Bodalal, Z., et al.
Publicado: (2021)

The Role of Radiation Oncology in Immuno‐Oncology
por: Meng, Xiangjiao, et al.
Publicado: (2019)

Tumor microenvironment-adjusted prognostic implications of the KRAS mutation subtype in patients with stage III colorectal cancer treated with adjuvant FOLFOX
por: Park, Hye Eun, et al.
Publicado: (2021)

Immuno-oncology trends: preclinical models, biomarkers, and clinical development
por: Franklin, Maryland Rosenfeld, et al.
Publicado: (2022)

Germline genetic host factors as predictive biomarkers in immuno-oncology
por: Chat, Vylyny, et al.
Publicado: (2019)

Expression Profile and Prognostic Significance of EPHB3 in Colorectal Cancer
por: Jang, Bo Gun, et al.
Publicado: (2020)

Practical issues of biomarker-assisted targeted therapy in precision medicine and immuno-oncology era
por: Lee, Dae Ho
Publicado: (2018)

Challenges and Opportunities in Dose Finding in Oncology and Immuno‐oncology
por: Ji, Yan, et al.
Publicado: (2018)

Multiplicity of Advanced T Category–Tumors Is a Risk Factor for Survival in Patients with Colorectal Carcinoma
por: Park, Hye Eun, et al.
Publicado: (2018)

Expression of Immuno-Oncologic Biomarkers Is Enriched in Colorectal Cancers and Other Solid Tumors Harboring the A59T Variant of KRAS
por: Lou, Emil, et al.
Publicado: (2021)

Prognostic Significance of EPHB2 Expression in Colorectal Cancer Progression
por: Jang, Bo Gun, et al.
Publicado: (2018)

Necroptosis in Immuno-Oncology and Cancer Immunotherapy
por: Sprooten, Jenny, et al.
Publicado: (2020)

Mevalonate Metabolism in Immuno-Oncology
por: Gruenbacher, Georg, et al.
Publicado: (2017)

Immuno-Oncology Essentials: An Overview
por: Hoffner, Brianna
Publicado: (2019)

Multiplex imaging in immuno-oncology
por: Zhao, Chen, et al.
Publicado: (2023)

Immuno-genomic landscape of osteosarcoma
por: Wu, Chia-Chin, et al.
Publicado: (2020)

Endometrial Carcinoma: Immune Microenvironment and Emerging Treatments in Immuno-Oncology
por: Rousset-Rouviere, Sandrine, et al.
Publicado: (2021)

SITC 2018 workshop report: Immuno-Oncology Biomarkers: State of the Art
por: Butterfield, Lisa H., et al.
Publicado: (2018)

Differential Features of Microsatellite-Unstable Colorectal Carcinomas Depending on EPCAM Expression Status
por: Kim, Jung Ho, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_0b76sdqq65iik1rc99gnfp60om